Tech Company Financing Transactions
Epiomed Therapeutics Funding Round
Epiomed Therapeutics, operating out of Irvine, scored $2.2 million from private investors.
Transaction Overview
Company Name
Announced On
5/1/2013
Transaction Type
Venture Equity
Amount
$2,249,999
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Mauchly 316
Irvine, CA 92618
USA
Irvine, CA 92618
USA
Phone
Website
Email Address
Overview
Epiomed Therapeutics is focused on the discovery and development of novel anti-emetic compounds for both the human and veterinary markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Helton
Chief Operating Officer
Ernest Pfadenhauer
Browse more venture capital transactions:
Prev: 5/1/2013: NowThis venture capital transaction
Next: 5/1/2013: RetailNext venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs